Skip to main content
Journal ArticleOPEN ACCESS

Impact of neurological symptom burden on the survival prognosis in a real-life cohort of patients with non-small cell lung cancer brain metastases

  • Steindl A
  • Yadavalli S
  • Gruber K
  • et al.
Annals of Oncology (2019) 30 v148
DOI: 10.1093/annonc/mdz243.012
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BackgroundThe high efficacy of targeted treatments in a- to oligosymptomatic non-small cell lung cancer (NSCLC) brain metastases (BM) revived the long discussion on BM screening. Therefore, we aimed to investigate the prognostic impact of symptomatic burden in patients with newly NSCLC BM in a large real-life cohort.

Cite

CITATION STYLE

APA

Steindl, A., Yadavalli, S., Gruber, K. A., Seiwald, M., Frischer, J. M., Gatterbauer, B., … Berghoff, A. S. (2019). Impact of neurological symptom burden on the survival prognosis in a real-life cohort of patients with non-small cell lung cancer brain metastases. Annals of Oncology, 30, v148. https://doi.org/10.1093/annonc/mdz243.012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free